Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
14
1
2
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
7.1%
1 terminated/withdrawn out of 14 trials
83.3%
-3.2% vs industry average
21%
3 trials in Phase 3/4
0%
0 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Cognitive Remediation and Supported Education in Psychotic Disorders
Role: collaborator
Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia
Role: collaborator
Inference-Based Cognitive Therapy Versus Exposure and Response Prevention for Obsessive-Compulsive Disorder
Role: lead
Evaluation of a Cognitive Psychophysiological Treatment for Tourette Syndrome and Tic Disorders
Role: lead
Cognitive-behavioral Therapy for Treatment of Post-traumatic Stress Disorder and Related Problems
Role: collaborator
Evaluation of a Cognitive Therapy (Inference-based-therapy) for the Treatment of Obsessional Compulsive Disorder
Role: lead
Effects of Online and Recovery-oriented Peer Support Groups Facilitated by Peer Support Workers in Times of COVID-19
Role: lead
Convergent and Concurrent Validity Between Clinical Recovery and Personal-civic Recovery in Mental Health
Role: lead
Post-traumatic Stress Injuries Among Paramedics and Emergency Dispatchers
Role: lead
Virtual Reality Therapy for Treatment-resistant Auditory Hallucinations in Schizophrenia
Role: collaborator
Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics
Role: collaborator
Inflammatory Markers and Cognitive Function in Major Depression
Role: lead
Effect of Antidepressants on White Matter Structure
Role: lead
RCT of CBT Combined With D-Cycloserine for Treating PTSD
Role: collaborator
All 14 trials loaded